Emerging from the UK, retatrutide, a new peptide , is creating considerable excitement within the scientific community regarding its ability for physique management . This dual GIP and GLP-1 agent agonist appears to provide a significant benefit over existing therapies, showing encouraging results in early clinical trials . Researchers believe its